Asterix Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 220.84%
About Asterix Pharma
Asterix Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 October 2020 (Four years and three months 25 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pavwan Droliaa and Pashupati Thakur serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51100MH2020PTC347265
- Company No.
347265
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Asterix Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pavwan Droliaa  | Director | 06-Oct-2020 | Current |
| Pashupati Thakur | Director | 06-Oct-2020 | Current |
Financial Performance of Asterix Pharma.
Asterix Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Asterix Pharma?
In 2022, Asterix Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asterix Pigments And Paints Private LimitedPavwan Droliaa is a mutual person
Asterix Reinforced LimitedPavwan Droliaa and Pashupati Thakur are mutual person
- Parshuram Polymer Private Limited
Pavwan Droliaa and Pashupati Thakur are mutual person
- Asterix Polymers And Coatings Private Limited
Pavwan Droliaa and Pashupati Thakur are mutual person
- Asha Scrap Trading Private Limited
Pavwan Droliaa is a mutual person
- Asterix Aadharbhut Sanrachna Limited
Pavwan Droliaa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asterix Pharma?
Asterix Pharma has a workforce of 0 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asterix Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asterix Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
